Search

Your search keyword '"Claudia S"' showing total 2,751 results

Search Constraints

Start Over You searched for: Author "Claudia S" Remove constraint Author: "Claudia S" Database OpenAIRE Remove constraint Database: OpenAIRE
2,751 results on '"Claudia S"'

Search Results

3. Organizational Culture Changes in the Company during the Covid-19 Pandemic

4. Exploring Academic Performance of Medical Students in an Integrated Hybrid Curriculum by Gender

6. Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti–PD-1 in Metastatic Non–Small Cell Lung Cancer

7. Lateral flow test engineering and lessons learned from COVID-19

8. Diagnostic performance of point-of-care ubiquitin carboxy-terminal Hydrolase-L1 assay in distinguishing imaging abnormalities in traumatic brain injury: A TRACK-TBI cohort study

10. Prognostic Understanding and Goals of Palliative Radiotherapy: A Qualitative Study

11. Leadership Development to Advance Health Equity: An Equity-Centered Leadership Framework

13. Complete distribution of the genus Laevilitorina (Littorinimorpha, Littorinidae) in the Southern Hemisphere: remarks and natural history

14. Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19

15. Diffusion Tensor Imaging Reveals Elevated Diffusivity of White Matter Microstructure that Is Independently Associated with Long-Term Outcome after Mild Traumatic Brain Injury: A TRACK-TBI Study

16. The effects of a 10-minute triceps surae stretching session persist after 60 min: a randomized clinical trial

18. An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD

19. COVID-19 convalescent plasma

20. Vitamin K antagonist reversal strategies: Systematic review and network meta‐analysis from the <scp>AABB</scp>

23. Genetic footprints of Quaternary glacial cycles over the patterns of population diversity and structure in three Nacella (Patellogastropoda: Nacellidae) species across the Magellan province in southern South America

24. Elucidating the local structure of V substitutes in In2S3 as potential intermediate band material by X-ray absorption spectroscopy and first principles calculations

25. Improving HIV Pre Exposure Prophylaxis (PrEP) uptake and initiation: process evaluation and recommendation development from a national PrEP programme

27. Prognostication and Goals of Care Decisions in Severe Traumatic Brain Injury: A Survey of The Seattle International Severe Traumatic Brain Injury Consensus Conference Working Group

28. Response of Superoxide Dismutase (SOD) to Homogeneous and Heterogeneous Food Sources in Bumblebees (Bombus terrestris) and Honeybees (Apis mellifera)

29. Supplementary Figures and Tables from Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti–PD-1 in Metastatic Non–Small Cell Lung Cancer

30. Data from Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti–PD-1 in Metastatic Non–Small Cell Lung Cancer

31. Brain and heart in Emergency Department

32. Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components

33. Current advances in transfusion medicine 2021: A critical review of selected topics by the AABB Clinical Transfusion Medicine Committee

34. Ingreso de nitrógeno y fósforo al lago Atitlán (Guatemala) vía deposición atmosférica

36. TonoVet Plus®: Higher reliability and repeatability compared with Tono‐Pen XL™ and TonoVet® in rabbits

37. Predicting Clinical Outcomes 7–10 Years after Severe Traumatic Brain Injury: Exploring the Prognostic Utility of the IMPACT Lab Model and Cerebrospinal Fluid UCH-L1 and MAP-2

40. Developing a National Trauma Research Action Plan: Results from the Neurotrauma Research Panel Delphi Survey

41. Supplemental Materials, Supplementary Tables 1-3 from A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer

42. Supplemental Figure S1 from A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer

43. Data from A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer

44. Supplementary Table 1 from A Transcriptional Profiling Study of CCAAT/Enhancer Binding Protein Targets Identifies Hepatocyte Nuclear Factor 3β as a Novel Tumor Suppressor in Lung Cancer

45. Data from A Transcriptional Profiling Study of CCAAT/Enhancer Binding Protein Targets Identifies Hepatocyte Nuclear Factor 3β as a Novel Tumor Suppressor in Lung Cancer

46. A cell-penetrant peptide blocking C9ORF72 -repeat RNA nuclear export reduces the neurotoxic effects of dipeptide repeat proteins

47. The Long Story of Ebselen: From about One Century of its Synthesis to Clinical Trials

48. Globally invariant metabolism but density-diversity mismatch in springtails

49. Phenotypic variability in traits related to flight dispersal in the wing dimorphic species Triatoma guasayana

50. Pelage Variation and Morphometrics of Closely RelatedCallithrixMarmoset Species and Their Hybrids

Catalog

Books, media, physical & digital resources